Summary: An international research team developed a postage-stamp-sized electrochemical sensor made from laser-patterned graphene to measure dopamine noninvasively in tear fluid. Engineered to analyze biological fluids without invasive procedures, the device accurately identified precise dopamine concentrations in artificial human tears, demonstrating potential for rapid, point-of-care screening for neurodegenerative disorders such as Parkinson’s disease.
Key Facts
- The tear-based diagnostic approach: Traditional methods for tracking Parkinson’s disease and related conditions are often slow or invasive. Tears offer a quick, painless alternative that can reflect systemic neurochemical changes in near real time, enabling easier sample collection and potential routine monitoring.
- Laser-induced graphene manufacturing: To keep production costs low and fabrication simple, researchers used a focused laser on a thin plastic film to convert selected regions into electrically conductive graphene. The resulting sensor measures roughly the size of a postage stamp.
- Electrochemical detection of dopamine: When a tear sample contacts the graphene surface, dopamine undergoes electrochemical oxidation at the electrode, changing the electrical signal. These voltage or current changes produce distinct, measurable spikes that correspond to dopamine concentration.
- Parkinson’s-relevant sensitivity: The sensor was calibrated with artificial human tears containing varied dopamine concentrations. It reliably detected dopamine levels comparable to those reported in tear samples from people with Parkinson’s disease, including the low concentrations relevant for early detection.
- Selective performance in complex fluids: Human tears contain many proteins, salts, and organic molecules that could interfere with measurements. In laboratory tests, the device showed strong selectivity for dopamine and maintained accurate results despite the complex background matrix.
- Wide operational range for early detection: The sensor detects dopamine across a broad dynamic range, from well below typical healthy baselines to several times above them. This range increases the chance of identifying small, early declines in dopamine long before overt motor symptoms appear.
Source: ACS
Overview: Researchers publishing in ACS Omega report the development of an affordable electrochemical sensor designed to detect dopamine, a neurotransmitter central to movement, learning, motivation, and emotional regulation. The team validated the device using artificial tear fluid and found it could accurately detect a wide range of dopamine concentrations, supporting its potential for noninvasive biomarker monitoring.
The study’s authors emphasize that a small tear sample could one day provide useful information about neurological health. The sensor’s simplicity and low cost make it a promising candidate for point-of-care diagnostics that monitor dopamine-related disorders.
“Our aim is to enable ultra-early detection of neurological disorders so clinicians can intervene before major symptoms develop,” says corresponding author Neftalí Lênin Villarreal Carreño.
Dopamine imbalances are implicated in several neurological and psychiatric conditions. For Parkinson’s disease in particular, dopamine concentrations decline as neurons that produce the neurotransmitter degenerate. Existing monitoring techniques—blood tests, urine analysis, or implanted sensors—can be invasive or slow, motivating the search for alternative sample types such as tears.
To build the sensor, the team used a laser to convert specific regions of a thin polymer sheet into conductive graphene, a process known as laser-induced graphene. The finished electrode produces a measurable electrochemical signal when dopamine present in a tear sample reacts at the graphene surface.
In laboratory experiments, dopamine was added to synthetic tear fluid to evaluate the sensor’s analytical performance. The device not only detected low concentrations of dopamine comparable to those reported in tear samples from Parkinson’s patients but also retained accuracy when common tear constituents were present.
“The sensor detects dopamine from levels below average healthy baselines up to several times higher,” notes coauthor Lucas Minghini Gonçalves. “That sensitivity increases the likelihood of spotting an initial dopamine decline early, which is crucial for timely therapeutic decisions.”
The authors conclude their results lay the groundwork for future studies using real human tear samples and for the development of point-of-care devices capable of monitoring neurological biomarkers with a simple tear collection.
Funding: The research acknowledges support from the Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), the Rio Grande do Sul Research Foundation (Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul), the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico), and the AgroHealth project supported by the Center for Embedded Devices and Research in Digital Agriculture (CEDRA) with funding from the Brazilian Company for Industrial Research and Innovation (EMBRAPII).
Key Questions Answered:
A: Tears contain biochemical components that mirror substances circulating in the bloodstream and, indirectly, in the central nervous system. Neurotransmitters and metabolic byproducts can reach the tear film through lacrimal gland exchange and systemic circulation. Because tear collection is minimally invasive and yields a relatively clean sample, tears can provide a practical window into neurochemical changes that relate to brain health.
A: The technique, known as laser-induced graphene, uses a focused laser to thermally transform selected areas of a polymer substrate into porous, conductive graphene. This material has high electrical conductivity and a large electroactive surface area. When tear fluid contacts this graphene electrode, target molecules such as dopamine undergo oxidation or reduction reactions that change the electrode current, producing a measurable signal proportional to concentration.
A: Clinical motor symptoms of Parkinson’s disease typically appear after significant loss of dopamine-producing neurons. Identifying subtle dopamine declines well before motor symptoms develop could allow earlier therapeutic intervention and monitoring strategies aimed at slowing or modifying disease progression, potentially preserving neurological function for a longer period.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional contextual information was added by staff.
About this neurotech and Parkinson’s disease research news
Author: Sarah Michaud
Source: ACS
Contact: Sarah Michaud – ACS
Image: The image is credited to Neuroscience News
Original Research: Open access. “What your tears could reveal about your brain” by Anderson Thesing, Bruno Vasconcellos Lopes, Bruno da Silveira Noremberg, Daiane Dias, Guilherme Kurz Maron, Irene Teresinha Santos Garcia, Lucas Minghini Gonçalves, Neftalí Lênin Villarreal Carreño, Raphael Dorneles Caldeira Balboni, Sabir Khan. ACS Omega. DOI: 10.1021/acsomega.6c03287
Abstract
What your tears could reveal about your brain
Dopamine is essential for motor control, cognition, and emotional regulation. Abnormal dopamine levels are linked to disorders such as Parkinson’s disease and schizophrenia, underscoring the need for sensitive, selective, and noninvasive detection methods.
This study details the creation of a high-performance, nonenzymatic electrochemical sensor based on laser-induced graphene, functionalized with nickel nitrate and urea, to detect dopamine in solution. The sensor’s design increases electroactive surface area and enhances electron transfer, improving sensitivity and selectivity.
Electrochemical techniques—cyclic voltammetry and differential pulse voltammetry—were used to characterize selectivity and analytical performance. Structural analysis by scanning electron microscopy and Raman spectroscopy confirmed formation of a porous, electroactive graphene network uniformly modified with nickel ions and nitrogen-containing groups.
These surface modifications increased the number of active sites for dopamine oxidation and improved electron transfer rates. Electrochemical results showed a linear detection range of 0.25–16.44 μmol·L–1, a limit of detection of 17.86 nmol·L–1, and a limit of quantification of 54.14 nmol·L–1 in phosphate-buffered solution, with R2 = 0.98. In synthetic tear fluid, the sensor provided consistent responses across concentrations from 3.23 to 9.32 μmol·L–1, and it demonstrated strong recovery rates in real-sample analyses, indicating suitability for complex biological matrices.